Ashley Wentworth is senior director, Vault Quality, at Veeva Systems.

Ashley Wentworth

The pace of quality transformation in life sciences continues to accelerate as global pharmaceutical companies and fast-growing biotechs look to simplify and automate complex processes. Investments in technology
are expected to continue well beyond 2023, with the quality management systems (QMS) market forecasted to grow at a 10% compound annual growth rate until 2030 (1).

Industry leaders are driving positive change and charting the path toward unified quality processes that bring together people, partners, and systems. For example, The Center for Breakthrough Medicines is a contract development and manufacturing organization (CDMO) that adopted advanced quality solutions to support its vision of building the world’s largest cell and gene therapy manufacturing and testing facility (2).

However, more work remains to stay ahead of evolving market conditions, regulatory requirements, and customer expectations. A continued commitment to driving innovation will be critical for companies to keep up with industry changes and deliver new therapeutics to patients morequickly while mitigating risks. In this article, four key trends that will shape the future of quality and manufacturing are identified, examined, and discussed.

Pharmaceutical Technology’s February 2023 Outsourcing Innovation eBook

Pharmaceutical Technology’s Outsourcing Innovation eBook


eBook: Outsourcing Innovation, February 2023
February 2023
Pages: 10–11

When referring to this article, please cite it as A. Wentworth, “Forecasting Trends in Pharma Innovation" 

Pharmaceutical Technology Outsourcing Innovation

Articles

In the coming year, pharmaceutical innovation will be fueled by key trends throughout the quality sector.